FDA Panel Backs Ketamine-like Drug for Depression

Despite the panel's approval, two of five key studies of esketamine failed to meet their primary goals. When taking esketamine, some patients experienced sedation, blood pressure spikes and dissociation (feeling disconnected from surroundings) within two hours of taking the drug, CNN reported.

from WebMD Health https://wb.md/2N341Ss